Glucometer Prescription for Diabetes Management
Patients with diabetes requiring insulin therapy should receive a prescription for a blood glucose meter with FDA-approved accuracy standards, test strips (quantity based on testing frequency), lancets, and a lancing device, along with mandatory education on proper technique and data interpretation. 1
Essential Prescription Components
For Insulin-Treated Patients
- Glucometer device: Must meet FDA accuracy standards (95% of readings within 15% for glucose ≥100 mg/dL, or within 15 mg/dL for glucose <100 mg/dL) 1
- Test strips: Prescribe sufficient quantity based on testing frequency—typically 120-300 strips per month for patients on multiple daily injections 1
- Lancets and lancing device: One lancet per test, though patients often reuse (not recommended but common in practice) 1
- Control solution: For periodic meter accuracy verification 1
Testing Frequency Guidelines
Patients on intensive insulin regimens (multiple daily injections or insulin pumps) should test at minimum 4 times daily, specifically: 1
- Before each meal (3 times)
- At bedtime (1 time)
- Additionally when suspecting hypoglycemia
- Before and after treating low blood glucose
- Before exercise and critical tasks like driving
Patients on basal insulin only or less intensive regimens may require 1-2 tests daily, though the optimal frequency remains less defined 1
Patients with type 2 diabetes on oral medications alone do not require routine blood glucose monitoring unless adjusting therapy, experiencing symptoms, or during illness 1
Critical Prescription Details
Meter Selection Criteria
- Only prescribe FDA-approved meters with proven accuracy from licensed distributors 1
- Verify the meter reports plasma-equivalent glucose values (not whole blood values, which read 10-15% lower) 1
- Ensure strips are compatible with the prescribed meter and check expiration dates 1
- Consider meters with data upload capability for better clinical management 1
Common Pitfalls to Avoid
Never prescribe glucometers for diabetes diagnosis—they lack the accuracy required and use capillary whole blood rather than venous plasma 1
Beware of interfering substances that affect accuracy: 1
- High-dose vitamin C (falsely elevates readings with glucose oxidase-based meters)
- Hypoxemia (affects readings)
- Extreme hematocrit values
- Maltose, galactose, or xylose (with some meter types)
Temperature and humidity outside manufacturer specifications will produce error messages or inaccurate readings 1
Mandatory Patient Education Requirements
Initial Training Must Cover
- Proper finger-stick technique including hand washing, site rotation, and adequate blood sample collection 1
- Quality control procedures using control solutions 1
- Interpretation of results and when to adjust insulin, food, or activity 1
- Recognition of meter errors and when laboratory confirmation is needed 1
- Data recording and sharing with healthcare team (logbook or electronic upload) 1
Ongoing Evaluation
Reassess technique at every routine visit—user error is a major source of inaccuracy 1
Evaluate the patient's ability to use BGM data to guide treatment decisions, not just perform the test 1
Alternative: Continuous Glucose Monitoring
Consider prescribing real-time CGM or intermittently scanned CGM instead of or in addition to BGM for patients on any insulin therapy, as CGM provides superior glycemic control and hypoglycemia detection 1
- CGM is strongly recommended (Grade A evidence) for adults with type 1 diabetes on intensive insulin regimens 1
- CGM should be used as close to daily as possible; intermittently scanned devices require scanning at minimum every 8 hours 1
- CGM devices must meet FDA iCGM standards for integration with insulin delivery systems 1
CGM does not eliminate the need for BGM—most systems still require occasional fingerstick calibration or confirmation during discordant readings 1
Insurance and Access Considerations
Document medical necessity in the prescription: 1
- Specify insulin regimen type (basal-bolus, pump, etc.)
- Note testing frequency requirements
- Include diagnosis codes for diabetes type
Ensure uninterrupted supply—gaps in testing supplies compromise glycemic control and increase complication risk 1